Conferences  >  Medicine & Healthcare  >  Oncology

European Society of Veterinary Oncology

Spectus Conferences

The Organizing Committee of International Conference on Cancer and Oncology Research invite you to participate in the Cancer Conference, which will be held during May 30-31, 2024 at Rome, Italy The main theme of conference is “Exploring the Recent Research and Advancements in Cancer and Oncology Research”. This Conference will provide a unique opportunity for researchers, healthcare practitioners, paramedics and trauma care specialists from around the world to communicate and share innovative thoughts and practices designed to optimize patient care.

Phone: [03023084943];     Email: spec-cancer@spectusconferences.org

Skin Cancers Tumor heterogeneity and Cancer Metastasis Translational Biology to Medicine in Innovative oncology Immune Responses & DNA Repair - Cancer Fields Cancer Genetics Cancer Therapy & Treatments Surgical Oncology Single-cell and Spatial Multiomics in Cancer Research Cancer Prevention & Research Cancer Signaling Next Generation Cancer Models Antibody-based Therapeutics Against Cancer Radiation Oncology

The European Association for Cancer Research (EACR) & EuCanImage

On the morning before our 2024 Congress begins, we are holding a specialised and free-to-attend EuCanImage workshop. Taking place between 09:00 and 14:00 CEST on Monday 10 June, this session will focus on the clinical and technical considerations of trustworthy Artificial Intelligence in multi-country oncology imaging, using experiences from The H2020 EuCanImage project as a basis for discussion.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, cancer research techniques, oncology imaging, artificial intelligence, data collection, large-scale data analysis, breast cancer data, liver cancer data, colon cancer data, rectum cancer data, colorectal cancer data, radiomics, deep learning, bioinformatics, biostatistics, diagnostics and biomarkers, prevention and early detection, metastasis, treatment response, clinical applications, technical considerations.

The European Association for Cancer Research

The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations. The programme includes cutting-edge scientific talks on various topics, industry symposia and spotlights, educational sessions, meet-the-expert panels, career discovery sessions, and a vast poster display. Topics to be covered include: modulating the tumour microenvironment; drug resistance; mechanism-based clinical trials; precision cancer medicine in the post-genomic era; senescence, dormancy, and related cell states; metabolism and cancer; cell-based therapies; spatial analysis of tumours/spatial transcriptomics; mechanical forces of cancer; mechanisms of tumour metastases; targeting mitochondria in cancer; liquid biopsies; drugging tumour suppressor genes; imaging the tumour microenvironment; making cold tumours hot; drugging the RAS Pathway; modeling cancer; and aging, gender, and cancer.

Event Organisers: New Way Management;     Email: eacr@newway-management.com

cancer research, cancer research conference, oncology, cancer models, liquid biopsies, tumour microenvironment, tumour metastasis, cancer metabolism, cancer cell states, cell-based therapies, drug resistance, genomics, spatial transcriptomics

Deutsche Gesellschaft für Radioonkologie e.V. (German Society for Radiation Oncology)

At the annual congress of the German Society of Radiation Oncology (DEGRO), all those working in radiation oncology have the opportunity to discuss all aspects important for the development of radiation oncology in a concentrated form and thus come to a broad exchange of knowledge.

Kongressorganisation;     Phone: [+49 3643 2468-126];     Email: degro-registrierung@KUKM.DE

radiooncology, radiotherapy, nuclear medicine, oncology, radiology, radiation, hematology, medicine, nuclear physicians, medical technologist for radiology

Radiology, Nuclear Medicine and Radiation Therapy,    Hematology

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in Hamburg & via Livestream, 21.-22.06.2024. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Phone: [+49 (0) 6192 47072 00];     Email: info@fomf.de

Continuing Medical Education (CME),    Hematology

The European Association for Cancer Research

This highly interactive online meeting for early-career researchers focuses on career development. It will cover all the topics that our ECR members tell us they need – such as leadership skills, personal growth, translating research, and bridging the gap between academia and industry – and will offer plenty of opportunities for delegates to speak directly with the experts. The target audience for this conference is: scientists in the early phase of their career who want to develop a career in cancer research. The programme is tailored for scientists in the process of starting their independent path, as well as for researchers engaging with the clinical and industrial applications of their work.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, cancer research careers, oncology, oncology careers, career guidance, leadership skills, cancer research leadership, personal development, translating research, working in academia, working in industry, science sustainability, grant writing, science creativity, science diversity, personal brands, translational cancer research, basic cancer research, preclinical cancer research

European Society for Medical Oncology (ESMO)

Brought to you by the European Society for Medical Oncology (ESMO), the congress will be the place to present very impactful new data in GI oncology. The scientific sessions will be complemented with high quality educational sessions and excellent networking opportunities.

In recent years we have seen remarkable progress in the treatment options available for patients with GI cancers and ESMO is committed to ensuring that there is a clear roadmap to help facilitate the implementation of new practice changing discoveries in the clinic for the benefit of all patients with GI cancers and whose wellbeing is our primary concern. The ESMO Gastrointestinal Cancers Congress will provide global visibility for original clinical and translational research.

Phone: [+41 (0)91 973 19 62];     Email: gicongress@esmo.org

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer, Pancreatic Cancer, Biliary Tract Cancer, Neuroendocrine Tumors, Colon Cancer, Rectal Cancer, GIST, Anal Cancer, Gastrointestinal Cancers

Gastroenterology,    Translational Medicine, Clinical Trials

Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate under microenvironment- and therapy-induced stress conditions. Recent technical developments have revealed the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression. The 11th ISCaM meeting, in Brussels (Belgium), will gather renowned experts in the cancer metabolism field to discuss the most recent knowledge related to metabolic alterations in cancer, and how this can be translated to the clinics to treat cancer patients.

Immunometabolism, Lipid metabolism and ferroptosis, Metabolism and therapy resistance, Tumor microenvironment and disease progression, Epigenetics, circadian clock and cancer metabolism, Tumor acidosis and imaging

European Molecular Biology Organization – EMBO

Fields Institute

This workshop aims to showcase the state-of-the-art mathematical and computational models that are in use in mathematical oncology, with a particular focus on the fourteen hallmarks of cancer. New modeling challenges arise from these hallmarks. Some of the hallmarks relate to the characteristics of the cancer cells themselves (sub-cellular and cellular level), while others include more global effects such as blood circulation, the immune response, the effect and role of the microenvironment, mechanical forces, and the microbiome. Matching the biological diversity of the cancer hallmarks, is the diversity of mathematical approaches and techniques that have been used and are in use to give insight into the growth and spread of cancer – for example, continuum and discrete models; ordinary and partial differential equation models; individual-based and agent-based models; hybrid models; deterministic and stochastic approaches; analytical and computational approaches. Many of these processes act on very different spatial and temporal scales. Hence a new integrated multiscale mathematical modeling framework is needed to include new aspects and insights, such as spatial stochastic models and local and non-local partial differential equation models.

Modeling and Simulation,    Systems Biology and Computational Biology

Jožef Stefan Institute

As in previous editions of the conference, the ICPM will bring together professionals from the fields of plasma, medicine, biology and biochemistry in order to develop a common language, to better define key challenges and open questions and to move toward effective solutions. This time it will be organized jointly with IWPCT covering plasma for cancer therapy on Monday, Sep. 9th. Prior to the conference, the traditional Summer School will take place, starting on the weekend, Sunday, Sep. 8th, and going through mornings from Monday, Sep. 9th to Wednesday, Sep. 11th. Registrations for the summer school will be conducted separately from the registrations for the conference.

Email: icpm10@ijs.si

plasma, medicine, cancer treatment,

Plasma and Gas-discharge Physics, Nuclear Fusion,    Medicine (in general), Internal medicine

European Helicobacter and Microbiota Study Group

The European Helicobacter and Microbiota Study Group (EHMSG) is a multidisciplinary group composed of representatives from most countries of the EU. It was founded in 1987 by a collaboration of pioneers in the field of Helicobacter and expanded its remit in 2016 to embrace the collective gastrointestinal microbiota. This includes dissemination of medical, scientific and technical information in order to promote health and decrease the burden of digestive diseases.

Each year, EHMSG hosts a conference consisting of a one-day postgraduate course followed by a 2-day workshop.

Event Secretariat;     Phone: [+431405138318];     Email: workshop@ehmsg.org

Helicobacter, Microbiota, IBD, FMT

Gastroenterology,    Medicine (in general), Internal medicine

Fields Institute

This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.

Modeling and Simulation,    Systems Biology and Computational Biology

European Society of Oncologic Imaging

The ESOI Touchdown 2024 event is an annual meeting organized by the European Society of Oncologic Imaging, where participants can follow various lectures by leading scholars and practitioners on oncologic imaging.

ESOI Office;     Email: office@esoi-society.org

radiology, oncologic imaging, oncology

The European Association for Cancer Research (EACR)

This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.

kenes exhibitions

The RNA Therapeutics Symposium aims to harness the transformative potential of RNA technology for a broader spectrum of cancer therapeutics. Bringing together a diverse array of experts, including RNA biologists, systems analysts, immunologists, and drug development specialists, this event fosters a collaborative environment. It facilitates the exchange of cutting-edge research, the development of a unified scientific lexicon, and the acceleration of research and development efforts in RNA therapeutics.

Phone: [+972 74 745 7435];     Email: skrein@kenes-exhibitions.com

RNA Therapeutics RNA Vaccines  RNA medicines RNA Manufacturing RNA technologies immunology Biotech Cancer

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de

Fields Institute

This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .

Modeling and Simulation,    Systems Biology and Computational Biology

The European Association for Cancer Research

This conference will gather top experts in the field of cancer metabolism to discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. Topics to be covered include: metabolic reprogramming in cancer beyond anabolism, metabolic transformation in cancer cells, metabolic signalling in cancer, metabolic cross-talk in the tumour microenvironment, metabolic regulation of gene expression, immune cell metabolism in cancer, nucleotide metabolism and cancer, metabolic approaches to cancer therapy, and systemic metabolic changes and their effects on cancer progression. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of cancer metabolism.

Conference Officer: Chris Iliffe;     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer metabolism, adaptations of cancer, tumour biology, tumour vulnerabilities, cancer cell biology, stromal cell biology, metabolic cell wiring, cell anabolism, molecular properties of cancer cells, cancer genomics, cancer cell signalling, nutrient signalling, cancer metabolic alterations, metabolic cross-talk, the tumour microenvironment, the tumour macroenvironment, gene expression, immune cell metabolism, metabolic approaches to cancer therapy, cancer progression, cancer research, oncology

Fields Institute

Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.

Modeling and Simulation,    Systems Biology and Computational Biology

As usual, the annual EANO meeting will kick off with an Educational Day on Thursday, October 17 and the main programme will commence on Friday, October 18. The congress encourages exchange and collaboration between all relevant disciplines: Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals, and aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours. EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central nervous system. The successful 2023 EANO meeting in Rotterdam attracted more than 1000 participants from all continents and was very highly rated!

Coalesce Research Group

We are glad to announce the 4thEuropean Congress on Cancer and Oncology Research on October 28-29, 2024 at Rome, Italy with the theme “Breaking Barriers: Collaborative Approaches in Cancer Research”. Our Aim is to bring global scientists/ researchers and business professionals to one platform. Oncology Research 2024 includes the series of B2B & B2C meetings, Oral Talks, Poster Presentations, and Workshops & Exhibitions by Industries, Academicians, Professors, and Young Forum Researchers & Students.by providing collaboration spaces and break-out rooms with tea and lunch for speakers, and delegates between sessions with invaluable networking time for you.

Phone: [1-718-543-9362];     Email: sarahlivingstone178@gmail.com

Cells and Cell Structure Cancer Systems Biology Sarcoma Colorectal Cancer Breast-cancer Blood cancer Skin cancer Gynecologic Cancer Head and Neck Cancer Genetic Cancer Nanotechnology in cancer Organ Specific Cancer Pediatric Oncology Medical Oncology Radiation Oncology Neuro Oncology Tissue regeneration and Oncology Cancer Epidemiology Cancer Treatment & Therapy Covid & Its impact on cancer Cancer Immunotherapies Cancer Biomarkers Cancer Metastasis Cancer drugs Market Tumor Virology and Immunology Radiology and Medical Imaging Cancer Chemotherapy and Pharmacology

Spandidos Publications

ISMM28 will focus on the latest research findings and cutting-edge technologies in the field of molecular medicine, with leading experts and scholars gathering from all over the world. ISMM28 creates a broad academic platform where participants will have the opportunity to share their research results, exchange academic views, and discuss the future direction of molecular medicine.

Organizing Committee;     Phone: [+86-15361286025];     Email: jiangjie@yujiab.com

Molecular medicine, oncology, SCI, academic conferences

Medizinisches Zentrallabor – Abteilung Transfusionsmedizin und Klinische Hämostaseologie, Klinik für Hämatologie, Zelltherapie und Hämostaseologie Bereich Hämostaseologie, MVZ Labor Dr. Reising-Ackermann und Kollegen

event lab. GmbH;     Phone: [0341 30 88 84 62];     Email: asauerland@eventlab.org

Hematology,    Vascular Medicine, Angiology

Fraunhofer Institute for Cell Therapy and Immunology, University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Hospital Leipzig.

Fraunhofer Institute for Cell Therapy and Immunology, Jens Augustin;     Email: info@lion-conference.com

oncology, immunotherapy, gene therapy, cell therapy

Immunology and Allergic Diseases,    Stem-cell Research & Therapy

The European Association for Cancer Research

Our popular Liquid Biopsies series returns for its fourth edition to bring together a slate of recognised experts who will explore how complex multi-modal liquid biopsy assays could be taken from the laboratory into clinical practice. Topics to be covered include the implementation of liquid biopsy in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multi-modal biomarkers, and how artificial intelligence can be applied to the field. This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals.

Conference Officer: Hannah Barrs;     Phone: [N/A];     Email: hannah.barrs@eacr.org

liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multi-modal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening

ESMO - European Society for Medical Oncology

ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

ESMO Asia 2024 Secretariat;     Email: asiacongress@esmo.org

oncology, translational research, clinical trials, breast cancer, CNS, precision medicine, gastrointestinal tumours, genitourinary tumours, gynecological tumours, haemathological malignancies, head and neck cancers, immunotherapy, melanoma, sarcoma, rare tumours, thoracic cancer, supportive care, palliative care, Clinical Practice Guidelines, radiology

Translational Medicine, Clinical Trials,    Continuing Medical Education (CME)

The European Association for Cancer Research (EACR)

One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.